When the dust settles on the Covid-19 crisis, the investing public may have to face significant changes in the huge U.S. health-care system. How effectively the U.S. can beat back the novel coronavirus, and what parts of the system shine or disappoint, may well determine whether the federal government expands its role in the system or reduces it. Health care accounts for more than one-sixth of total gross domestic product. The values of drugmakers, insurers and hospital operators all hang in the balance.

Source: Wall Street Journal March 16, 2020 11:03 UTC